Evaluation of High tone and Duloxetine on diabetic neuropathy

Phase 3

• Conditions: E13.40; Diabetic neuropathy.; Other specified diabetes mellitus with diabetic neuropathy, unspecified

• Registration Number: IRCT20200827048547N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 October 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Age over 18 years
Type 1 and 2 diabetes
24-hour mean pain score based on VAS pain visual scale> 4mm

Exclusion Criteria

Mood Disorder
Disseminated anxiety disorder
Avoid substance use
A history of less than a year or more than 15 years of diabetes
Receive medication to control diabetic polyneuropathy within 2 weeks before starting the study
Existence of neuropathy due to another
Peripheral vascular disease
Pregnant or lactating women
History of epilepsy
Uncontrolled acute angle-closure glaucoma
GFR less than 32 mmol / min
Liver disease
Heart disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Painful vision scale. Timepoint: During the study and on a weekly basis. Method of measurement: VAS scale.